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Background
The basal-like subtype of human breast cancers has no
clinically defined marker profile. Recent studies have
shown that Met as well as certain Src family kinases are
over-expressed in basal-like breast cancers and correlate
with disease progression and poor prognosis. Our group
has also demonstrated a potential regulatory role of Stat3
on Met activation or turnover, adding to the previously
identified roles of Stat3.
Materials and methods
We have elected to test the efficacy of inhibitors of Met
(PF-02341066), Src family kinases (Dasatinib), and Stat3
(CPA7) in blocking the invasive potential of breast cancer
cells, using the human basal-like breast cancer cell line
MDA-MB-231 transfected with a constitutively active Src
mutant (MDA-Src cells). The efficacy of inhibitors in dis-
rupting the invasive capacity of cells was assessed using
transwell invasion assays and colony growth in a 3D
Matrigel culture model mimicking basement membrane
matrices.
Results
Treatment of MDA-Src cells with Stat3 or Src inhibitors
markedly reduced branching extensions, and induced
growth arrest and cell death of colonies in a dose-
dependent manner. Interestingly, treatment with the Met
inhibitor also decreased branching extensions but failed to
inhibit cell colony forming ability or proliferation. Further-
more, we have found that induction of morphological
responses in 3-D culture occurs at ~15-fold lower concen-
tration of the inhibitors than is necessary to observe
decreased expression of drug targets in 2D culture.
Transwell assays also showed a decrease in invasion
of CPA7 and Dasatinib treated cells. Interestingly,
PF2341066 treatment of cells did not affect transwell
invasive potential, suggesting that other effectors than
Met may be involved.
Conclusions
Our findings further implicate a rate-limiting role of Src,
Stat3 and Met in the process of invasion in human
basal-like cells, and may lead to improved predictive
biomarkers for targeting of aggressive breast cancer sub-
types which exploit this pathway.
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